1 IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING
Agropharm LimitedBuckingham Place,Church Road, Penn,High WycombeBucksHP10 8LNTel: +44 (0) 1494 816575Factory: +44 (0)1952 740333Fax: +44 (0) 1494 [email protected]
Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. CLASSIFICATION
The Full Text for all R-Phrases are Displayed in Section 16
GENERAL INFORMATIONProvide rest, warmth and fresh air.
INHALATIONRemove victim immediately from source of exposure. Move into fresh air and keep at rest. Get medical attention if any discomfort continues.
INGESTIONDO NOT INDUCE VOMITING! NEVER MAKE AN UNCONSCIOUS PERSON VOMIT OR DRINK FLUIDS! If vomiting occurs, keep head low so that stomach content doesn't get into the lungs. SKIN CONTACTWash skin thoroughly with soap and water. Get medical attention if irritation persists after washing.
EYE CONTACTDust in the eyes: Immediately flush with plenty of water or eyewash solution for up to 10 minutes. Remove any contact lenses. Continue to rinse for at least 15 minutes. Get medical attention if any discomfort continues.
EXTINGUISHING MEDIAThe product is non-combustible. Fire can be extinguished using: Water spray, fog or mist. Carbon dioxide (CO2). Dry chemicals, sand, dolomite etc. SPECIAL FIRE FIGHTING PROCEDURESAvoid breathing fire vapours.
PROTECTIVE MEASURES IN FIREUse protective equipment appropriate for surrounding materials.
PERSONAL PRECAUTIONSWear protective clothing as described in Section 8 of this safety data sheet. Avoid inhalation of dust.
ENVIRONMENTAL PRECAUTIONSDo not discharge into drains, water courses or onto the ground.
SPILL CLEAN UP METHODSCollect powder using special dust vacuum cleaner with particle filter or carefully sweep into closed container. Avoid generation and spreading of dust. Dispose of according to local regulations.
USAGE PRECAUTIONSAvoid handling which leads to dust formation. Persons susceptible for allergic reactions should not handle this product.
STORAGE PRECAUTIONSStore in tightly closed original container in a dry and cool place. Keep separate from food, feedstuffs, fertilisers and other sensitive material.
STORAGE CLASSMiscellaneous hazardous material storage.
PROCESS CONDITIONSProvide eyewash station.
ENGINEERING MEASURESNo specific ventilation requirements noted, but forced ventilation may still be required if air contamination exceeds acceptable level.
RESPIRATORY EQUIPMENTNo specific recommendation made, but protection against nuisance dust must be used when the general level exceeds 10 mg/m3. Wear effiecient dust mask. HAND PROTECTIONUse suitable protective gloves if risk of skin contact.
EYE PROTECTIONWear dust resistant safety goggles where there is danger of eye contact.
STABILITYStable under normal temperature conditions and recommended use.
CONDITIONS TO AVOIDAvoid contact with water.
HAZARDOUS POLYMERISATIONWill not polymerise.
HAZARDOUS DECOMPOSITION PRODUCTSNone under normal conditions.
GENERAL INFORMATIONThis product has low toxicity. Only large volumes may have adverse impact on human health.
INHALATIONHigh concentrations of dust may irritate throat and respiratory system and cause coughing.
INGESTIONNo harmful effects expected in amounts likely to be ingested by accident.
SKIN CONTACTProlonged contact may cause redness, irritation and dry skin.
EYE CONTACTDust in the eyes will cause irritation.
ECOTOXICITYThe product contains a substance which is very toxic to aquatic organisms and which may cause long term adverse effects in the aquatic environment. ACUTE FISH TOXICITYVery toxic to aquatic organisms.
DISPOSAL METHODSThis material and its container must be disposed of in a safe way.
This product is not classified as hazardous for transport purposes
Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
This material and its container must be disposed of in a safe way.
Contains PERMETHRIN. May produce an allergic reaction.
UK REGULATORY REFERENCESChemicals (Hazard Information & Packaging) Regulations. Control of Pesticides Regulations 1986. HSE No. 5170.
GENERAL INFORMATIONThe information contained in this Safety Data Sheet is believed to be true and correct, as of the issue date. The accuracy and completeness of this information and any recommendations, or suggestions are made without warranty or guarantee. Since the conditions of use are beyond the control of our company, it is the responsibility of the user to determine the conditions of safe use for this product. REVISION COMMENTSSection 1 updated. Section 13 updated.
Harmful by inhalation and if swallowed.
May cause sensitisation by skin contact.
Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
This information relates only to the specific material designated and may not be valid for such material used in combination with any other materials or in any process. Such information is, to the best of the company's knowledge and belief, accurate and reliable as of the date indicated. However, no warranty guarantee or representation is made to its accuracy, reliability or completeness. It is the user's responsibility to satisfy himself as to the suitability of such information for his own particular use.
maleate at 4 mg/mL [Fenistil injectable solution, Novartis]), Anaphylaxis to Dimenhydrinate Caused by the 2 piperazines (cetirizine hydrochloride at 10 mg/mL [Zirtek Theophylline Component tablet in normal saline, UCB] and levocetirizine dihydrochloride at 5mg/mL [Xozal tablet in normal saline, UCB]) and a piperidine (desloratadine at 5mg/mL [Aerius tablet in normal Allergy Departmen
My AF journey My journey began when I reached menopause. It started slowly with palpations that lasted over a couple of days for a couple of hours at any one time. The pounding in my chest started to annoy me so I presented to the emergency department to find out what it was. The diagnosis was atrial fibrillation (AF) and I was informed that I needed a cardiologist to investigate the cause.